Accretion Pharmaceuticals (NSE:ACCPL) Total Stockholders Equity: ₹547.1 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
22 GF Score
Price ₹200.00
! 6 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals Total Stockholders Equity?

Accretion Pharmaceuticals NSE:ACCPL -0.99% 22 Total Stockholders Equity is ₹547.1 Mil as of Mar. 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 22/100. The stock has 6 warning signs investors should review.

Accretion Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Mar. 2026 was ₹547.1 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Accretion Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2026 was ₹49.22. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Accretion Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.23.

Accretion Pharmaceuticals  (NSE:ACCPL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Accretion Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(547.085-0)/11.116
=49.22

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Accretion Pharmaceuticals's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(114.587 + 8.625) / 547.085
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals Total Stockholders Equity Related Terms

Accretion Pharmaceuticals Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals Total Stockholders Equity Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
30.76 38.43 53.48 152.87 547.09

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial 53.48 0.00 152.87 465.79 547.09
NSE:ACCPL
22GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of ₹547.1 Mil mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a Total Stockholders Equity of ₹547.1 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Accretion Pharmaceuticals and its competitors.
Is Accretion Pharmaceuticals' Total Stockholders Equity too high?
Accretion Pharmaceuticals' current Total Stockholders Equity is ₹547.1 Mil. Overall, Accretion Pharmaceuticals has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Total Stockholders Equity compare to LLY and JNJ?
Accretion Pharmaceuticals' Total Stockholders Equity of ₹547.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Accretion Pharmaceuticals and its competitors. Accretion Pharmaceuticals's current Total Stockholders Equity is ₹547.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Total Stockholders Equity of ₹547.1 Mil. The current Total Stockholders Equity is ₹547.1 Mil. Accretion Pharmaceuticals' overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Total Stockholders Equity is ₹547.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
22GF Score

Get the complete analysis for NSE:ACCPL

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹200.00
Price